From: Evaluation of sleep quality and depressive symptoms among medical students during COVID-19 pandemic
Total (N = 121) Mean (SD) | Male (N = 56) Mean (SD) | Female (N = 65) Mean (SD) | P value | |
---|---|---|---|---|
Age | (1.6)23.7 | 23.8 (1.7) | 23.6 (1.5) | 0.866 |
Cigarettes smoking (N (%)) | 10 (8.3) | 7 (12.5) | 3 (4.6) | 0.116 |
Antidepressant use (N (%)) | 23 (19.0) | 8 (14.3) | 15 (23.1) | 0.219 |
Part time job (N (%)) | 41 (33.9) | 25 (44.6) | 16 (24.6) | 0.02 |
PSQI > 5 (N (%)) | 90 (74.4) | 40 (71.4) | 50 (76.9) | 0.264 |
PHQ-9 > 10 (N (%)) | 41 (33.9) | 19 (33.9) | 21 (32.3) | 0.992 |
PSQI components | ||||
Subjective sleep quality | 1.31 (0.80) | 1.27 (0.82) | 1.34 (0.78) | 0.628 |
Sleep latency | 1.39 (0.93) | 1.39 (0.97) | 1.38 (0.90) | 0.961 |
Sleep duration | 1.57 (1.02) | 1.55 (1.09) | 1.55 (0.98) | 0.999 |
Habitual sleep efficiency | 0.33 (0.65) | 0.28 (0.52) | 0.38 (0.74) | 0.378 |
Sleep disturbances | 1.17 (0.49) | 1.11 (0.53) | 1.22 (0.45) | 0.226 |
Use of sleep medication | 0.43 (0.83) | 0.46 (0.85) | 0.40 (0.82) | 0.675 |
Daytime dysfunction | 1.55 (0.88) | 1.38 (0.91) | 1.71 (0.82) | 0.037 |